Cleared Traditional

K961310 - STORZ PREMIERE II MICROSURGICAL SYSTEM (CX SERIES)

K961310 is an FDA 510(k) clearance for STORZ PREMIERE II MICROSURGICAL SYSTEM ..., manufactured by Storz Instrument Co.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K961310 · Storz Instrument Co. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1996
Decision
84d
Days
Class 2
Risk

K961310 is an FDA 510(k) clearance for the STORZ PREMIERE II MICROSURGICAL SYSTEM (CX SERIES). Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Storz Instrument Co. (St. Louis, US). The FDA issued a Cleared decision on June 27, 1996 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Storz Instrument Co. devices

FDA 510(k) Submission Details - K961310

510(k) Number K961310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 1996
Decision Date June 27, 1996
Days to Decision 84 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 110d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 199
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K961310.
CTM REUSABLE PAK
K962430 · Circuit Tree Medical, Inc. · Jul 1996
CTM DISPOSABLE PAK
K962431 · Circuit Tree Medical, Inc. · Jul 1996
OCUSYSTEM ART ADVANTAGE
K961243 · Surgical Design Corp. · Jul 1996
SYNERGIST POWER PACK
K960414 · Chiron Vision Corp. · Apr 1996
STORZ DP4310DELUXE PHACO PACK WITHOUT REFLUX
K955901 · Storz Instrument Co. · Mar 1996
ALCON SERIES 20000 LEGACY MACKOOL SYSTEM
K955789 · Alcon Laboratories · Mar 1996